Carvana’s Crash Accelerates

Shares of online car retailer Carvana fell to a fresh all-time low as bankruptcy fears spread. ๐Ÿ˜ฑ

The company reportedly signed a pact with creditors who hold roughly 70% ($4 billion) of its unsecured debt. The binding deal requires its creditors to act together in negotiations with the company. This could potentially streamline the negotiation process where Carvana can seek to restructure debt or secure new financing.

After the news broke, Wedbush analyst Seth Basham downgraded the stock from neutral to underperform. He also reduced his price target from $9 to $1. He joins the group of other analysts who continue to throw in the towel on the stock. Other analysts, however, downplayed the rumors and said the company has a sufficient short-term cushion to get through the end of 2023.

The bears remain in the driver’s seat for now, with $CVNA shares falling another 43% today… ๐Ÿ“‰

Nio & Nikola’s Never-Ending Story

No matter the day, there seems to be an endless stream of electric vehicle (EV) industry news. Let’s get into today’s headlines. ๐Ÿ“ฐ

First up is China’s Nio, which just received an additional $2.2 billion investment from Abu Dhabi’s CYVN Holdings, which raised its stake to 20.1%. The fund had last invested in Nio during July, with a $1 billion investment.ย 

Read It

Peloton’s New Partnership

With Peloton’s turnaround strategy not yet bearing the fruit it had anticipated, the company continues to lean on partnerships to grow market share. For example, in September, the company entered a 5-year strategic partnership with Lulemon to bring its content to the athleisure brand’s exercise app. It also made Lululemon Peloton’s primary athletic apparel partner. ๐Ÿ‘Ÿ

It’s still too early to tell whether or not that cooperative effort is working, but management seems to think further initiatives like it will help boost revenues. As a result, it’s partnering with TikTok to bring short-form fitness videos and other content to the social media platform.

Read It

Pfizer’s Flop Continues

It’s been a rough ride for pharmaceutical giant Pfizer since the end of the pandemic, and that rollercoaster ride continues today. ๐ŸŽข

The company last announced earnings in October but needed to update Wall Street on its 2024 forecast. It cited weak demand for its Covid products as the reason for a weaker-than-anticipated revenue and earnings forecast.

Read It

March Madness Continues At NYCB

When regular people talk about March Madness, they’re referring to college basketball. But when traders and investors talk about March Madness, they’re referring to a regional bank stock imploding.

We’re about a year out from three regional banks failing and/or being rescued, and now the sharks are circling New York Community Bancorp. The long story short, until today, is that the regional lender has too much commercial real estate exposure, weak internal controls over financial reporting, and a new CEO trying to right the ship. ๐Ÿ—ž๏ธ

Read It